MANUFACTURERS LIFE INSURANCE COMPANY, THE
InsurancePosition in GSK — GSK plc
CIK 928047
TORONTO, A6
Position in GSK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$98,955,278
-$32,290,736 QoQ
Shares Held
1,887,739
-20.6% QoQ
Ownership
0.094%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#26
of 1,032 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MANUFACTURERS LIFE INSURANCE COMPANY, THE holds $5,071,810,314 across 14 Drug Manufacturers - General names. GSK ranks #9 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,337,665 | $1,604,435,664 | |
| 2 | JNJ |
Johnson & Johnson
|
3,746,452 | $951,486,414 | |
| 3 | AZN |
Astrazeneca PLC
|
3,673,390 | $696,548,211 | |
| 4 | ABBV |
AbbVie Inc.
|
2,603,988 | $655,267,540 | |
| 5 | AMGN |
Amgen Inc
|
1,150,794 | $416,725,523 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,073,176 | $266,403,116 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,093,987 | $138,214,317 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
2,176,661 | $125,419,206 |
All Filings in GSK
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $98,955,278 | 1,887,739 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $131,246,014 | 2,378,076 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $180,038,050 | 3,671,249 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $175,902,378 | 4,075,588 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $161,234,995 | 4,198,828 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $43,314,961 | 1,118,094 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $44,601,782 | 1,318,799 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $41,635,830 | 1,018,489 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $38,904,211 | 1,010,499 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $43,274,950 | 1,009,446 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $38,233,579 | 1,031,667 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $35,888,768 | 990,035 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $34,616,062 | 971,270 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $27,213,220 | 764,846 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $19,464,186 | 553,904 | Shares | Defined | 2023-08-11 | |
| 2022-09-30 | $17,371,440 | 590,263 | Shares | Defined | 2023-08-11 | |
| 2022-06-30 | $32,011,787 | 749,792 | Shares | Defined | 2023-08-11 | |
| 2022-03-31 | $31,870,089 | 745,959 | Shares | Defined | 2023-08-11 | |
| 2021-12-31 | $38,115,179 | 881,209 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $33,024,512 | 881,209 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $15,815,663 | 404,954 | Shares | Defined | 2021-08-12 | |
| No filing history on record for this holder in this stock. | ||||||